Item 1A. Risk Factors
3K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
There have been no material changes from the significant risk factors and uncertainties previously disclosed under the heading "Risk Factors" in the Company's annual report on Form 10-K for the year ended December 31, 2023, that if they were to occur, could materially adversely affect the Company’s business, financial condition, operating results and/or cash flow. For a discussion of the Company’s risk factors, refer to Item 1A. “Risk Factors” contained in the Company’s annual report on Form 10-K for the year ended December 31, 2023.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
MOODY'S PURCHASES OF EQUITY SECURITIES
For the three months ended June 30, 2024
| Period | Total Number of Shares Purchased (1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Program | Approximate Dollar Value of Shares That May Yet be Purchased Under the Program**(2)** | ||||||||||||||||||||||
| April 1- 30 | 263,932 | $ | 384.68 | 261,485 | $ | 1,138 | million | |||||||||||||||||||
| May 1- 31 | 192,057 | $ | 394.81 | 188,051 | $ | 1,064 | million | |||||||||||||||||||
| June 1- 30 | 218,251 | $ | 410.84 | 218,200 | $ | 975 | million | |||||||||||||||||||
| Total | 674,240 | $ | 396.08 | 667,736 |
(1) Includes surrender to the Company of 2,447; 4,006; and 51 shares of common stock in April, May, and June, respectively, to satisfy tax withholding obligations in connection with the vesting of restricted stock issued to employees.
(2) As of the last day of each of the months. On February 5, 2024, the Board of Directors authorized $1 billion in share repurchase authority. At June 30, 2024 there was approximately $975 million of share repurchase authority remaining. There is no established expiration date for the remaining authorization.
During the second quarter of 2024, Moody’s issued a net 100,000 shares under employee stock-based compensation plans.
Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information